Home
About
Careers
Contact
More
We are pioneering first-in-class, engineered IgA as neutrophil engagers to fight cancer.
Anne Altmeyer, PhD, MBA, MPH
CEO
Howard Stern, MD, PhD
CSO
Cassandra Choe-Juliak, MD, MS
CMO
Dan Felitsky, PhD
VP, Immuno-oncology
Ona Miller, PhD
Project Manager
Elena Paltrinieri, PhD
Senior Research Scientist
Jeanette Leusen, PhD
Associate Professor,
UMC Utrecht
Anne Altmeyer
Maarten de Jong
Moelis & Company
Sonia Gulati
Global BioAccess Fund
Dan McHugh
Emerson Collective
Aaron Nelson
Novartis Venture Fund
Stefan Pflanz
Boehringer Ingelheim
Edward van Wezel
BioGeneration Ventures